Authorities points alert on newfound side-effect of painkiller Meftal

Srinagar, Dec 07: The Indian Pharmacopoeia Fee (IPC), the pharmaceutical normal physique, has issued a drug security alert concerning the generally used painkiller mefenamic acid, commercially often known as Meftal.

The Pharmacovigilance Program of India (PvPI), accountable for monitoring hostile drug reactions (ADRs), carried out a preliminary evaluation revealing a possible aspect impact—Drug Rash with Eosinophilia and Systemic Signs (DRESS) syndrome.

DRESS syndrome is a extreme allergic response that may be deadly, with roughly 10% of affected people going through mortality.

Regardless of Meftal not being an over-the-counter product, it’s broadly utilized in India for varied functions, together with relieving menstrual pains, complications, muscle and joint ache, and is often administered to kids for prime fever.

The alert urges healthcare professionals and sufferers to watch potential hostile reactions intently.

If such response is encountered, the alert suggested, individuals ought to report the matter to the nationwide coordination centre of the PvPI underneath the fee by submitting a kind on the web site – www.ipc.gov.in – or by way of android cellular app ADR PvPI and PvPI Helpline No. 1800-180-3024.